Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures

Fig. 2

Serial CT and MRI images. a Axial fat saturated T1-weighted MRI image with contrast enhancement showing a lobulated contoured poorly enhancing tumor (arrow) in the right kidney. Tumor invasion was observed at IVC (arrow head) and metastatic lymph nodes (open arrow) were noted. b Despite temsirolimus treatment, primary tumor and metastatic lymph node size increased. c After radical nephrectomy, hepatic metastasis (arrowhead) was noted on a follow up CT scan, which (d) became aggravated despite axitinib therapy. e However, at 2 months after bevacizumab plus erlotinib therapy, the multiple hepatic metastases had nearly disappeared

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us